EARLY PRO-2 SYMPTOM REMISSION FOLLOWING GUSELKUMAB INDUCTION TREATMENT: RESULTS THROUGH WEEK 12 OF THE PHASE 2 GALAXI 1 STUDY
William J. Sandborn 1
Tadakazu Hisamatsu 2
Kathleen Weisel 3
Susana Gonzalez 3
Mary Ellen Frustaci 3
Zijiang Yang 4
Jewel Johanns
Matthew Germinaro
Brian Feagan
Aniita Afzali
Walter Reinisch
Jane Andrews
Omoniyi J. Adedokun
Chenglong Han
1 University of California San Diego,San Diego,United States
2 Kyorin University,Tokyo,Japan
3 Janssen Research & Development, LLC,Spring House,United States
4 Janssen Research & Development, LLC,S
Session
IBD (Posters)
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]